Science Policy Around the Web November 17, 2020

On Monday, biotech firm Moderna announced preliminary findings of their COVID-19 vaccine clinical trial demonstrating 94.5% efficacy. Moderna reported that 90 people who had received placebo shots became ill with COVID-19, compared to only 5 in the vaccine group. Moreover, of the 90 positive patients in the placebo group 11 developed severe cases of COVID-19, compared to no severe cases in the treatment group. These findings come a week after Pfizer and Biontech announced that preliminary findings from their own vaccine clinical trial had demonstrated that the vaccine was more than 90% effective….